CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT07421726
NCT07421726N/ACompleted

Controlled Terminal Reperfusion With Cold Preservation Solution in the cDCD III Donor

IRCCS Azienda Ospedaliero-Universitaria di Bologna·observational·Posted Feb 19, 2026·Updated Feb 19, 2026

In Brief

An observational study for Transplant Patients and 2 related conditions. Completed, enrolled 20 participants across 1 site.

Detailed Summary

The goal of this observational study is to describe the details of a controlled administration strategy of cold preservation solution or oxygenated cold preservation solution at the end of Abdominal Normothermic Regional Perfusion (A-NRP) in Controlled Donation afeter Circulatory determination of Death (cDCD) III donors. The main purpose is to: develope a standardized protocol for this type of donor Data collected from partecipants, deceased donors belonging to cDCD III category, willl be analysed through descriptive stastistics.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesItaly
Collaborators--

Timeline

N/ACompletedFinished
2026
First PostedFeb 19, 2026
Enrollment StartMar 17, 2025
Primary CompletionDec 16, 2025
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 4 months ago